3D Tech Omega Zeta is a global digital media company and creator of Sciencestanding, an educational platform that has produced and currently offers the world’s first extensive online course in Oncology, CELLULAR AND MOLECULAR BIOLOGY OF CANCER. Sciencestanding’s complete course of 3D animation videos and Interactive Self-Evaluation Tests is unique in its scope and relevancy in that as well as providing an in-depth review of the principal Hallmarks of Cancer, it also includes learning modules that cover relevant subjects in Oncology such as Immunotherapy. The Sciencestanding platform’s collaborating partners include some of the most prestigious institutions in the world, such as the Harvard-MIT Biomedical Engineering Center. https://oncology.sciencestanding.com/
Activity: 3D Tech Omega Zeta will have representatives at their booth to provide insights to their new EdTech platform, sciencestanding. This includes the unique 3D audio-visual book, “The cellular and molecular biology of cancer.” A didactic learning experience whereby visitors to the booth can experience first-hand the 127 (3D) animated videos, over 900 interactive tests as well as multiple choice exam style questions. The course includes modules for students as well as those undertaking CME.
AORTIC is dedicated to the facilitation of research and training as well as the provision of relevant and accurate information on the prevention, early diagnosis, treatment, and palliation of cancer, including increasing public awareness of cancer and reducing the stigma associated with it. We strive to unite the African continent in achieving its goal to reduce the cancer burden on the continent and improve outcomes of the cancer patient in Africa through collaboration with health ministries and global cancer organisations.
Addressing the cancer burden and its disproportionate impact on developing countries is an urgent task that calls for increased international partnerships and collaborations. A task that AORTIC has undertaken in order to build capacity for cancer advocacy, research and training in Africa.
AORTIC will be hosting its 12th International Cancer Conference, “Cancer in Africa: Innovation, Strategies, Implementation”, in Maputo, Mozambique, from 5-8 November 2018 (www.aorticconfernce.org).
- Meet some of the AORTIC team – Put a face to the Name!
- Pin your country on our Interactive Map
- Keep in Touch! - Drop off your business cards to join our network
- Sign up for our electronic newsletters available in English, French & Portuguese
- Update or add your details to the AORTIC Cancer Network Online Map
- Learn more about AORTIC Special Interest Groups and programmes
- Learn more about AORTIC 2019 International Cancer Conference in Maputo, Mozambique
- Update your membership details
- Renew your membership
- Sign up as a member
- Give us your feedback
The American Cancer Society is the largest voluntary health organization whose mission is to save lives, celebrate lives, and lead the fight for a world without cancer. Our comprehensive mission includes research, public health campaigns, patient and family support, advocacy and cancer information.
- Showcase of the Cancer and Tobacco Atlases
- Global Health Executives will be on hand throughout the day to meet and greet conference participants and discuss global programs, particularly our HPV Vaccine initiative
ASCO is a multidisciplinary, global oncology society with nearly 45,000 members in over 150 countries. ASCO members are provided with resources and opportunities to:
• Stay on the cutting edge of scientific research and advances
• Connect and exchange views with oncology experts
• Gain insight into best practices for cancer care teams
• Volunteer and contribute to the Society
• Access professional development and leadership opportunities
Visit the ASCO Stand to learn about the value of membership and explore the robust suite of ASCO journals that oncology professionals use to stay at the forefront of oncology science, including Journal of Global Oncology. Join ASCO onsite and receive a free gift along with immediate access to member benefits, including 20% off educational products.
Activity: Visit the ASCO Stand to learn about the value of membership and explore the robust suite of ASCO journals that oncology professionals use to stay at the forefront of oncology science, including Journal of Global Oncology. Join ASCO onsite and receive a free gift along with immediate access to member benefits, including 20% off educational products.
More information soon
- AMRING Pharmaceuticals is a private-held, pharmaceutical company active in global markets, partnered with well-established global pharmaceutical companies
- AMRING supplies high quality medicinal products and medical devices, at high standards
- Our teams are highly motivated and focused on developing operations in a very efficient way
- We bring expertise in life sciences and adjacent activities. Agile business structure and ability to quickly leverage global resources at a local level
- Having its Headquarters in Lausanne, Switzerland, the group also includes 2 Regional Hubs in Paris, France and Bucharest Romania, 7 Affiliates and 6 Branch offices
- Our high quality and reliable products aim medical fields like oncology, respiratory and critical care
Astellas Pharma Inc., based in Tokyo, Japan, is a company deeply committed to changing the current landscape of cancer – from developing cutting-edge treatments to bringing non-treatment based innovations in cancer care to reality.
Activity: Astellas Oncology will be promoting the C3 Prize Live Pitch presentation on October 3, 2018 at 15:20 MYT. We will be showcasing the three Category Winners and encouraging WCC attendees to attend and vote for their favorite Grand Prize pick. We may also have a meet and greet with a previous 2017 award winner and 2018 winners as well as a potential celebrity judge.
BEACON Medicare Limited is a concern of BEACON Group and Global Marketing Partner of BEACON Oncology Limited. BEACON is the Number 1 Oncology company and one of the leading pharma companies of Bangladesh. The company has started its business operation in 2006 with a vision of caring global patient. BEACON manufactures more than 100 lifesaving anti-cancer products. Besides the conventional chemotherapy products, BEACON manufactures MABs, Targeted therapies, Nano and Lyposomal preparations. After meeting the local demand, BEACON exports its medicines globally. Patients of 120 countries including USA, Europe, and Australia are using BEACON’s medicines.
Best Cure Foundation was established in the Commonwealth of Virginia, USA in 2007 as a non-profit entity to promote healthcare and education globally. The purpose of the foundation is to work with citizens, medical professionals, government and non-government organizations and educational institutions, as well as charitable institutions around the world, to eradicate contagious disease, malnutrition and poverty, and provide superior healthcare at low cost. Everyone deserves the best healthcare. Education is the most effective way to eliminate poverty and promote global understanding and peace. Chapters will be set up globally to serve local and regional needs.
The Canadian Partnership Against Cancer was created by the federal government in 2006 with funding through Health Canada to work with Canada’s cancer community to reduce the incidence of cancer, lessen the likelihood of Canadians dying from cancer, and enhance the quality of life of those affected by cancer. As the steward of the Canadian Strategy for Cancer Control, the Partnership works with partners to reduce the burden of cancer for Canadians.
Activity: The Partnership's booth will include opportunities to meet our experts and learn more about our work to reduce the burden of cancer on Canadians. The booth will also include demonstrations of tools and resources available through the Partnership's digital properties as well as a selection of corporate and cancer control materials and publications.
Founded in 1997, Can-Care is the leader in the provision of innovative and personalised post care support services and products for cancer patients in Asia. We specialized in breast care products such as breast prosthesis, mastectomy bras, medical wigs, post operation compression range and fitting services that helps women improve their quality of life after cancer.
- Demo-station for Asia first 3D scanned customized breast prosthesis that gives perfect fit for each patient
- Free sample of special formulated shampoo for healthy hair scalp during chemotherapy
- Sit back relax with our Scalp cooling system treatment for prevention of hair loss during chemotherapy
Cancer Research UK’s vision is to bring forward the day when all cancers are cured. As the world’s largest independent funder of cancer research, we invested close to $500 million in 2017/18 in world-leading research into the prevention, diagnosis and treatment of cancer. We fund research across all 200 different types of cancer and in 35 countries globally, and have a network of over 100 partners including cancer societies, patient organisations, government agencies, funding organisations and corporates. In the UK, we work across a broad cancer control agenda and have pioneered innovative approaches to tobacco control and early diagnosis of cancer in particular. We are interested in working with international partners from all parts of the world to find new ways of moving towards our vision.
Cancer Society of Maldives (CSM) is a national community based (non-profit/non-governmental) organization formed for the purpose of reducing the incidence and impact of cancer in the Maldives. We aim to contribute towards the well being of our community by creating awareness about cancer, providing psychosocial support and circulating information and resources so as to enhance the experience of people fighting against cancer. It is one of our top priorities to conduct cancer research and to create a cancer patient registered data base in the Maldives.
- Display Maldives and CSM statistics
- Display programs conducted by CSM
- Colouring corner
- Interactive video presentation on how to conduct screening and awareness programs and challenges faced in countries like Maldives
Founded in 1984, China Anti-Cancer Association (CACA) is a non-governmental and non-profit organization in the field of oncology in China. CACA has established 60 professional societies and owned 60 organization members, and 30 provinces have set up local anti-cancer associations with a total individual members exceeding 150,000. The headquarter office is based in Tianjin with 38 full time working staffs.
The mission of CACA is devoted to decrease the incidence and mortality rates of cancer, increase the survival rate, and improve the cancer control both in China and the world. CACA is contributed to cancer prevention and treatment via organizing, mobilizing and supporting clinical, scientific and technological professionals in the field of oncology.
Prof. Daiming Fan, the Academician of Chinese Academy of Engineering, is the President and Prof. Ying Wang is the Secretary General of CACA.
Clinical Research Malaysia (CRM) exists to advance global health solutions for a brighter, more hopeful future for the people by providing speedy and reliable end-to-end clinical research support for quality studies. As these studies unfold, we work together with our partners to create an impetus in delivering better treatment to our end consumers, while at the same time creating high-skilled job opportunities.
The strength of our operation lies in our innate understanding of the local clinical research landscape and implementation of international standards. This, when considered in parallel to the fundamental backing of the government ministries, provides us with an incomparable advantage, as we work hand-in-hand with our partners from the nascent stages of development to materialisation of the end product.
In the journey towards a brighter and better future, we facilitate the entry of industry-sponsored research into Malaysia, working closely with the government and relevant authorities to ensure that all regulations and best practices are met.
In CRM, we credit the outstanding performance to the team we have anchored from within our organisation. Their endless pursuit of innovation and continuous improvement have propelled CRM forward to optimise the opportunities that come our way. In tandem with our passion for the clinical research landscape, we ensure core values of transparency, honesty, accountability and trustworthiness resonate throughout CRM. These qualities are also cascaded to our principal investigators and Study Coordinators, who act as the catalysts of the clinical research process.
As CRM vouches for an aspiring future in the clinical research industry, we have implemented mechanisms to expand hospital capacity for clinical trials and tests. This is possible by tapping into our vast talent pool consisting of principal investigators and medical assistants.
The College of Public Health of National Taiwan University has been so far the first and only one public health school being accredited by CEPH (Council on Education for Public Health) in Asia. Our mission is to improve the health and well-being of populations worldwide via education, research and service. Our vision is to be a leading institution that fosters future public health professionals and leaders, pursues innovative and creative researches, and be dedicated to developing effective solutions to global public health issues.
We prioritize important public health agenda, including community-based practice, global health, planetary health and sustainable development goals (SDGs) to tackle four common global health issues including the emerging environmental pollution due to industrialization and urbanization, the change of demographic make-up due to increasing aging population and low fertility rate, the evolution of transgenerational social behavior due to the advent of new technology of information and device, and the transition of health care system due to the force driven by health inequality.
Our aim is to develop a systematic framework from ecological to individual level to provide an innovative evidence-based, comprehensive, continuous, and precise heath care planning, policy and implementation pursuant to the guideline of UN SDGs.
ECS-Screening is a Swiss company that has pioneered the development of two unique laboratory tests for the detection of circulating progastrin. The presence of progastrin in the blood is linked to the presence of tumor cells. CancerREAD Smart helps health care providers screen patients for many cancer types, such as breast and colorectal cancers, even in their early stages. CancerREAD Lab helps doctors monitor how their patients’ cancers respond to therapy.
Activity: ECS-Screening is a Swiss company that has pioneered the development of two unique laboratory tests for the detection of circulating progastrin. The presence of progastrin in the blood is linked to the presence of tumor cells. Our solutions can help health care providers screen patients for many cancer types, such as breast and colorectal cancers, even in their early stages and to monitor how their patients’ cancers respond to therapy.
Come visit us at booth 26-29 to learn more.
The European School of Oncology was founded in 1982, with the aim of contributing to the reduction of deaths from cancer due to late diagnosis and/or inadequate treatment.
ESO’s mission is reﬂected in its motto “Learning to Care”, which emphasises the importance of the learning process, and the goal of caring for the patient in a holistic sense, in contrast to focusing purely on treating the disease.
Leading oncologists from around the world played a key role in founding of the School. Now, after more than 35 years, ESO is the oldest and most structured organisation exclusively dedicated to increasing the knowledge of health professionals in all fields of cancer medicine, under the auspices of an international scientific committee and advisory board.
More information soon
The Global Colon Cancer Association is a group of more than 40 patient advocacy organizations focused on colorectal cancers. We advocate for patient centered policies around the globe and support the creation of new groups.
The Specialist in Cancer Care
Healthcare Global Enterprises Ltd (HCG), India’s largest provider of cancer care is at the forefront of the battle against cancer. Through its network of comprehensive cancer centers spread across India, HCG has brought advanced cancer care to the doorstep of millions of people. For years, HCG has been defining the future of cancer care in India by designing, building and managing cancer centers with a steadfast vision: Adding life to years by redefining healthcare through global innovation.
Our intent is to help patients live longer, better lives and to improve cancer care.
At HCG, each center is a model of excellence, a place where physicians can achieve professional fulfillment and accomplish breakthroughs in patient care. HCG has grown rapidly and is now a leader in cancer care, managing a network of comprehensive cancer care centers pan India. Each center is provided with a business system, management expertise and capital resources to bring patient focused, state-of-the art cancer care to new regions.
The Health Promotion Administration (HPA), Ministry of Health and Welfare, provides comprehensive health promotion services from womb to tomb and from families to communities. The HPA gives priority to enhancing health literacy and promoting healthy lifestyles, spreading preventive healthcare and promoting effective prevention and screening, upgrading the quality of healthcare and improving chronic disease control and prognosis, creating a friendly and supportive environment, and bolstering healthy options and equality.
As for the cancer control, the Cancer Control Act was promulgated in 2003. Three phases (2005-09, 2010-13, 2014-18) of National Cancer Control Programs have been implemented since 2005 and the 4th phase will be started in 2019. Besides, the Tobacco Hazards Prevention Act was promulgated in 2009. Tobacco tax and surcharge are imposed. Meanwhile, Taiwan cancer control uses tobacco surcharge as its main financial resource.
Activity: Health Promotion Administration, Ministry of Health and Welfare, will display the achievements in cancer prevention, screening, treatment and palliative care in Taiwan. Visitors can write down his/her blessings on a sky lantern-shaped sticker, paste it on the blessing wall and take a photo with the Taipei 101 building. After that, visitors can write a post or check-in on his/her social media to receive a free sky lantern souvenir from Taiwan with limited quantity.
Hetero is one of India’s leading generic pharmaceutical companies and the world’s largest producer of anti-retroviral drugs for the treatment of HIV/AIDS. Backed by 25 plus years of expertise in the pharmaceutical industry, Hetero’s strategic business areas spread across APIs, generics, biosimilars, custom pharmaceutical services and branded generics. The company is globally recognized for its strengths in Research and Development, manufacturing and commercialization of a wide range of products.
Hetero has 36 state-of-the-art manufacturing facilities strategically located worldwide. And a majority of our facilities have been successfully audited and approved by stringent regulatory authorities like US FDA, EU, TGA-Australia, MCC-South Africa and others. Our portfolio includes 300 plus products encompassing major therapeutic categories such as HIV/AIDS, Oncology, Cardiovascular, Neurology, Hepatitis, Nephrology, Urology, Diabetes, Ophthalmology, Hepatology and Immunology etc.
Hetero has a strong global presence in over 126 countries and focusses on making affordable medicines accessible to patients worldwide.
Activity: Scientific quiz & Breast cancer awareness ribbon: give-away of wrist bands
Founded in 1963 by the late Prof. John H.C. Ho. The Hong Kong Anti-Cancer Society (HKACS) is a non- profit- making cancer organisation with the longest history in Hong Kong. Commitment to serving people in Hong Kong, we have been at the forefront of the fight against cancer for over 55 years.
The Hong Kong Anti-Cancer Society Jockey Club Cancer Rehabilitation Center (“JCCRC”) provides a one-stop nursing and rehabilitation service. With the aim of providing a comfortable “home away from home”, we render comprehensive nursing care and psychological, social and spiritual support to patients and their carers.
Throughout the year, we organise various public awareness campaigns, including cancer education programmes, cancer research funding, and establishing evidence-based guidelines for cancer detection and prevention. In terms of services, we provide holistic support and counselling services to cancer patients and their family members, direct assistance to cancer patients with financial difficulties through the free or subsidised drugs for treatment, Charity Bed Programme, Project Wish, and more. HKACS staff and volunteers also organise home visits and recreational activities regularly for cancer patients.
The advancement in Western medicine in cancer management is well-established. Nevertheless, some patients suffer many undesirable side effects from radiotherapy and/ or chemotherapy/ target therapy, which often adversely affect the body’s immunity function and thus the patients’ quality of life. The strength of Chinese Medicine lies in its capacity to regulate the human body’s internal environment or to restore its systems back to an optimal functional status (hemostasis).
The Hong Kong Anti-Cancer Society has been devoting efforts in fostering integration of Chinese & Western medicine. In order to let the delegates to learn more about the role of Chinese medicine in improving patients’ quality of life, some Chinese medicinal herbs for wellness (Goji berry/ Astragalus/ Chinese Yam/ Ginseng/ Red date/ Coix Seed) would be displayed for them to feel and smell while education booklets and souvenirs on Chinese medicine would be disseminated for free to the delegates at the booth.
Hospis Malaysia is a leading palliative care organization in Malaysia. In line with its focus on advocating for greater accessibility to palliative care in the country, it strives to strengthen its lead position in education and training in palliative care while offering the highest possible quality of palliative care to its patients.
Our vision is to provide the highest quality of palliative care so as to provide relief from and prevent pain and suffering associated with progressive and life-limiting illnesses.
We are committed to advancing palliative care programmes and research with the aim of ensuring that palliative care which is already part of the WHO definition of ‘Universal Health Care’ becomes fully integrated into the country’s healthcare system.
As a charitable organization which provides palliative care to patients at no charge, we are funded almost entirely by private donations. Our core service is our domiciliary palliative care service which is supported by a multidisciplinary team of doctors, nurses, a pharmacist and an occupational therapist. We also offer weekly outpatient rehabilitation sessions for our patients and monthly caregiver training workshops to empower caregivers to care for the patients at home.
Activity: Hospis Malaysia is launching “Speak Up – There’s an Elephant in the Room”, an art installation of 10 life-sized baby elephant models at KLCC Esplanade, from 1-14 October. Visit our mini ‘elephant in the room’ to learn more about how Hospis Malaysia is helping people start conversations that really matter when one is diagnosed with cancer…
IMU Healthcare is a modern integrated healthcare provider of the following services: Medical, Dental, Chiropractic and Chinese Medicine. The services range from basic primary healthcare to advanced specialties and sub-specialties suitable for patients of all ages and backgrounds. IMU Healthcare’s team of doctors, dentists and complementary medicine practitioners are focused on assisting patients with the knowledge of the many treatment options available and helping them reach the outcome that restores them to optimal health.
Activity: Visit IMU Healthcare booth for a complimentary dental assessment, chiropractic assessment and Chinese Medicine pulse reading. Our team of Chinese Medicine practitioners would also be sharing about acupuncture and pain management while our Dental team would be sharing about Oral Health for cancer patients.
The Instituto Nacional de Cancerología (INCan) is a national agency founded in 1946 as part of the Ministry of Health and is the governing body of cancer in Mexico.
The Institute’s mission is to provide state-of-the-art patient care, to train top medical professionals and to support pioneering research and discovery.
INCan is committed to dispensing patients with the best cancer care possible. Its innovative model of multidisciplinary, compassionate and collaborative care puts patients and their families at the center of all its activities. The Institute leads and conducts research to advance scientific knowledge in the causes, prevention, diagnosis and treatment of cancer and offers education for undergraduate and graduate students, trainees, professionals and the public.
The Instituto Nacional de Cancerología is the leading entity designated by the Ministry of Health to coordinate the development and implementation of the cancer registry and the national cancer control program in Mexico.
Activity: We want to highlight the presence and participation of Latin America in the congress, to be part of the experience and take advantage of the congress platform to share experiences and make connections with other cancer organizations and health professionals.
The International Kidney Cancer Coalition (IKCC) is an independent international network of patient organisations that focus exclusively, or include a specific focus, on kidney cancer. It is legally incorporated as a Foundation in the Netherlands. The organisation was born from a very strong desire among various national kidney cancer patient groups to network, cooperate and share materials, knowledge, and experiences.
Activity: We will be highlighting our work on World Kidney Cancer Day which takes place in June each year to help raise global awareness of kidney cancer.
We will also be highlighting our growing network of patient organisations.
Establishment of Korean Cancer Association (KCA)
‘Korean Cancer Research Association’ was established in November 1958 and it was renamed as the ‘Korean Cancer Association’ in June 1974.
Objective and Activities
The association is destined to make a contribution on the progress and improvement of oncology with the purpose of strengthening the relationship between association members.
- To develop the oncology
- Opening of Annual meeting with International Conference and Fall Symposium
- Cancer Research and Treatment (CRT) is indexed/tracked/covered by SCI, Medline, PubMed, PubMed Central, KoreaMed, CrossRef, Chemical Abstracts Service (CAS), SCOPUS, KoMCI, and Google Scholar.
- To support internal and external scientific activities of members
- Cooperation with other related societies
- 1,800 members from 144 Institutes or Hospitals in Korea
- Basic and clinical oncologists
MAHAK – the Society to Support Children Suffering from Cancer is a charity organization established twenty seven years ago and continues since as an independent NGO exclusively funded by benevolent citizens concerned with the welfare of children with cancer and their families which was impressively ranked as the 4th NGO by Société Generale de Surveillance (SGS) among 299 organizations in 2016. As of March 2018, MAHAK, operated with 829 paid staff and hundreds of volunteers scattered across Iran, providing full treatment, research, and psycho-social support to every Iranian and non-Iranian family whose child has cancer and is in need of financial and medical support. This inclusive service has been provided to over 30,000 cases by the end of March 2018 with over 17,000 active cases receiving treatment and psycho-social support in all public hospitals throughout the country with Pediatric Hematology-Oncology wards.
- Give-away of fabric bags as well as a few number of MAHAK children's handmade from recycled material of donation boxes
- Participants will be invited to continue a painting already started by MAHAK children.
MAKNA (Majlis Kanser Nasional or National Cancer Council) is a not-for-profit social enterprise founded by Dato’ Mohd Farid Ariffin. Inspired by his own son’s fight and struggles with cancer, MAKNA was born in 1994 and was officially launched in 1995.
In providing multi-faceted services, MAKNA prides itself as a home grown organisation that continues to play an important part helping cancer patients, regardless of background, race, creed, colour and station.
To mobilise resources in order to provide curative, preventive, research and support services to cancer patients and their families, high-risk groups and the general public, in Malaysia and the world.
To pool and utilise all efforts, expertise and finance of all sectors of the society to fight cancer and reduce related pain, morbidity and the suffering that cancer patients undergo.
The Max Foundation is a non-profit global health organization that believes all people living with cancer deserve access to the best treatment, care, and support.
We decrease premature mortality from cancer by channeling humanitarian donations of life-saving oncology products to underserved populations in countries where those products are not locally available. By partnering with the major cancer institutions and patient associations in low- and middle-income countries, we enable effective solutions for access to cancer treatment and strengthen local health systems in the process.
We know so many people living beyond their cancer diagnoses because of the access we are able to provide. We know the privilege of watching patients grow, get married, start careers, and give back to their communities. While treatment access means the world to us and our patients, there are many who do not realize the freedom, joy, and dignity that comes with access to a daily dose.
Activity: Participants will be given a copy of a children’s storybook produced by cancer survivors and advocates called Maximo and the Big C. Through the gift of the storybook, we hope attendees can bring a message about treatment access back to their own communities.
The McCabe Centre for Law and Cancer works to create a world free from preventable cancers and in which all people affected by cancer have equitable access to safe, effective and affordable cancer treatment and care.
The only centre of its kind in the world, the McCabe Centre for Law and Cancer promotes the effective use of law for the prevention and control of cancer, and other non-communicable diseases (NCDs), by building knowledge, expertise, capacity and networks at global, regional and domestic levels.
The McCabe Centre for Law and Cancer, established in 2012, is a Melbourne-based joint initiative of Cancer Council Victoria, the Union for International Cancer Control, and Cancer Council Australia.
More information soon
Shared with Singapore Cancer Society
The National Cancer Centre Singapore (NCCS) was established as a national cancer centre by an act of Parliament in 1999. Today, it is staffed by over three hundred researchers and cancer specialists working to provide earlier diagnosis, the latest treatments and more personalised patient care. It sees close to 65% of Singapore’s public sector cancer patients. NCCS pioneered the one-stop multi-disciplinary approach in cancer treatment and patient care, with services such as medical oncology, surgical oncology, radiation oncology, and supportive and palliative care.Many of its clinicians are also involved in research work as well as teaching and mentoring younger doctors. Their research work has been widely recognised internationally with many papers published in leading peer medical and scientific journals. NCCS has collaborations with several top overseas medical and research centres as well as pharmaceutical companies. NCCS is part of the Singapore Health Services cluster. Sited in the Outram campus, the 6-storey building houses both clinics and research laboratories, and is an ambulatory centre providing outpatient and day surgery services. It has more than 1,000 staff and manages about 150,000 patient visits a year.
The National Cancer Institute (NCI), part of the National Institutes of Health, is the U.S. government's principal agency for cancer research and training. NCI’s mission is to lead, conduct, and support cancer research across the nation to advance scientific knowledge and help all people to live longer, healthier lives. NCI’s scope of work spans a broad spectrum of cancer research across a variety of disciplines and supports research training opportunities at career stages across the academic continuum. The NCI Center for Global Health advances that mission by supporting and facilitating cancer research in the U.S. and abroad, building partnerships among cancer research institutions, and training scientists to address global cancer challenges.
Activity: The National Cancer Institute (NCI) booth is used to share information about the institute and its global health initiatives. The activities at the booth will include Meet the Expert sessions, where interested conference participants can attend short presentations by NCI experts, who will discuss programs and initiatives, resources, and opportunities throughout the institute, particularly as they pertain to global health. In addition, NCI will use the booth as an opportunity to set up small networking meetings for interested participants to meet with NCI staff.
The National Cancer Society of Malaysia (NCSM), is the first cancer not-for-profit, tax-exempt organisation in Malaysia, established in 1966. It is registered under the laws of the Malaysian Societies Act and Registrar of Societies Malaysia and the only charity that provides education, care and support for people affected by cancer and to the general public.
NCSM’s mission is “To ensure that no Malaysian fears cancer by creating an understanding of cancer that leads to prevention and early detection, and by providing the best possible care and support for those affected by cancer.”
Being the only charitable organisation that provides a holistic cancer–related services to cancer patients, caregivers and the public, we support them through our six centres:
SCREENING & EARLY DETECTION / Cancer and Health Screening Clinic
INVESTIGATION / Nuclear Medicine Centre
SMOKING CESSATION / Quit Smoking Clinic
SUPPORT & WELLNESS / Resource and Wellness Centre
INFORMATION & SUPPORT / Cancer Information Service
CARE / Children’s Home of Hope
Our programmes and activities are financed entirely by voluntary contributions from the public. We have six branches nationwide in Kuala Lumpur, Negeri Sembilan, Perak, Penang, Johor, Sarawak and Melaka.
- Batik Painting
- Congkak competition
- Exhibits painting artwork by cancer survivors
An alliance of 27 leading cancer centers devoted to patient care, research, and education, is dedicated to improving the quality, effectiveness, and efficiency of cancer care so that patients can live better lives. Through the leadership and expertise of clinical professionals at NCCN Member Institutions, NCCN develops resources that present valuable information to the numerous stakeholders in the health care delivery system. As the arbiter of high-quality cancer care, NCCN promotes the importance of continuous quality improvement and recognizes the significance of creating clinical practice guidelines appropriate for use by patients, clinicians, and other health care decision-makers. The primary goal of all NCCN initiatives is to improve the quality, effectiveness, and efficiency of oncology practice so patients can live better lives.
Activity: Give-away of goodies at the booth.
The Nigerian Cancer Society NCS is a non-governmental, not-for-profit organization, established with the aim to reduce the pain and suffering due to cancer in Nigeria. It was formed on 12 October 1968 and now has branches in all the 36 States of Nigeria, as well as NCS America and NCS Europe. It has several hundred volunteers and coordinates a national network of over 100 NGOs with various expertise in cancer control, research, advocacy, resource mobilization, awareness creation, and cancer education. For the 2018 WCC the Nigerian Cancer Society is supported by its affiliates the Medicaid Cancer Foundation, Raise Cancer Foundation, LEAH Foundation and ABC Foundation.
The Oman Cancer Association (OCA) is a non-governmental, non-for-profit umbrella organization. The inception of the Association was in the 2000 but was registered at the Ministry of Social Development in 2004. OCA is the brainchild of a 4 times cancer survivor Ms. Yuthar AlRawahi who started the initiative in 1999. The Oman Cancer Association is 18 years old and serves the community to achieve its vision, Mission, and Objectives. This is done through special projects, landmark projects, fundraising and creating awareness towards all cancers. Concentrating on awareness, empowerment, human resource development, and research. We collaborate and support other similar organization within the region and globally. Oman is one of the co-founders of the International Cancer Prevention Consortium - ICPC with the objective of cancer prevention and control and concentrating in education, training, and dedicated research. Through the ICPC Oman Cancer Association supports the low and middle-income countries – LMIC in their needs to fight cancers in their countries. We are very active within the region and also East Africa. Oman Has won a number of local, regional and UN awards for its landmark projects.
Pantai Jerudong Specialist Centre (PJSC) is a newly built beach front hospital with a breath-taking view of the South China Sea. It consists of three world class centres of excellence namely The Brunei Cancer Centre (TBCC), Brunei Neuroscience Stroke and Rehabilitation Centre (BNSRC) and Maxillofacial, Facial Plastic and Reconstructive Surgery Centre (MFPRSC), that are equipped with state-of-the-art medical and rehabilitative care facilities. With the visionary direction of PJSC's leaders, PJSC's centres of excellence and their services will continue to evolve and strive towards being 'a leading, innovative and specialised medical centre'.
PJSC's dedicated healthcare team take pride in their personalised approach to provide meaningful care with a difference to our patients and stakeholders. The human and people-centred touch immersed with essential core values are ingrained in every facet of our care for a more holistic 'WE CARE' approach. Additionally, resources are carefully selected and invested in provide comprehensive check-ups, consultations and treating patients with cancer, stroke and other neurological conditions, face head and neck related conditions with the latest technology, evidence-based treatment, healthy sporting lifestyle advice and outstanding rehabilitative programmes
PinkDrive, South Africa’s best-loved Breast Cancer Community Carer, is the indispensable, tangible breast cancer Non-Profit Company (NPC), powering South Africa’s mobile Women’s Health Mammography and Gynaecology Units. PinkDrive’s underlying message is ‘Early Detection Saves Lives’.
The PinkDrive mobile health project started with a vehicle compliment comprising of Southern Africa’s first Mobile Mammography Unit, a Mobile Educational Unit as well as three educational vehicles. Over the years, PinkDrive has invested in purchasing two additional mobile mammography units with the aim of reaching more communities and increasing impact. Initially, the project was based in Johannesburg Gauteng but now has a national footprint with satellite offices in the Durban, Pretoria, and Cape Town.
All PinkDrive units travel to semi-urban and urban areas around South Africa with the aim of enabling all medically uninsured access to women’s health services. These services include free education on women’s health, free mammograms, free pap smears, free clinical examinations and how to do breast self-examinations.
To date (June 2018), PinkDrive has provided more than 14 300 mammograms, conducted more than 125 200 clinical breast examinations and educated more than 359 600 people on breast health.
Activity: Information regarding PinkDrive and the work we do. Interaction with delegates on our unique programme and discussions of case studies.
Various giveaways (e.g. ribbons, brooches etc.) and information handouts;
Competition: Delegates can complete a Myth vs Fact worksheet.
The Princess Margaret Cancer Centre (PM) is the largest comprehensive cancer centre in Canada. We aspire to be at the forefront of cancer research, embrace the latest technology, and set new standards for patient care. The PM provides the full spectrum of cancer care with programs in medical oncology and hematology, radiation medicine, surgical oncology, psychosocial oncology, palliative care, rehabilitation and survivorship. Our programs are affiliated with the University of Toronto. We are a Regional Cancer Centre for the Toronto Central South Regional Program of Cancer Care Ontario, a provincial agency that oversees the delivery, quality and funding of cancer services.
We are engaged in a broad spectrum of cancer research from basic discovery to translational programs and clinical trials. We have been a member of the UICC for over 50 years and seek to achieve global impact through international partnerships that endeavor to accelerate progress in conquering cancer.
The Princess Margaret Cancer Foundation (PMCF) has been instrumental in raising and stewarding funds to deliver breakthrough research, exemplary teaching, and compassionate care. The PMCF has pioneered numerous large-scale fundraising campaigns, including the recent completion of the 5-year Billion Dollar Challenge which included $532 million in philanthropic support and $520 million in research grants.
Activity: The Princess Margaret Cancer Centre is pleased to launch Cancerpedia – a cohesive framework for comprehensive cancer centres or programs that are able to provide the full spectrum of care, serve as a hub for education and research, and are integrated into broader cancer control and health systems. The framework was constructed with the patient at the centre and provides a system-level perspective as well as a granular view of the fundamental resources and structures needed to build and maintain individual cancer centres and programs. Cancerpedia is relevant to high, middle and low resource settings and can serve as a self-assessment checklist for healthcare administrators and professionals looking to develop, scale up, or maintain a comprehensive cancer centre or program. The framework is openly accessible at cancerpedia.ca .
Join us on October 2nd during the afternoon break between 15:20 – 15:50 at booth E69 to learn more about the framework and help us launch Cancerpedia. Between Oct 1 – Oct 4, stop by booth E69 to participate in the Cancerpedia Challenge for a chance to win an iPad!
Qatar Cancer Society (QCS):
- A non-profit humanitarian charity founded in 1997
- The national cancer society of Qatar
- Chairman of the Board is H.E. Shk. Dr. Khalid Bin Jabor Al Thani
- Full member in the Union for International Cancer Control
- Founding member of the International Cancer Prevention Consortium
- Member in the National Cancer Program and National Cancer Committee of Qatar
To be the community partnership platform to make Qatar a leader in cancer prevention and its burden control.
We seek to prevent cancer and control its burden in Qatar by working with our partners to educate the community, and to support, empower and advocate for individuals living with cancer, and to engage in the professional development and scientific research in the field of cancer.
QCS organized around 1000 cancer education activities in the last 5 years, in addition to colorectal cancer conference in 2013 with 1500 participants, and breast cancer conference in 2016 with 3000 participants.
QCS supported 2000 individuals living with cancer in the last 5 years with total cost of USD 5.5 million.
Roche concentrates exclusively on innovative medicines and diagnostic approaches that offer decisive advantages over existing products and solutions. Our aim is to continue tailoring medicine as closely as possible to patients’ needs. As one of the world’s leading healthcare companies, and given our combined strengths in pharmaceuticals and diagnostics, there’s no one better suited for the task of developing personalised medicine.
Activity: At Roche’s booth, delegates can learn more about Personalised Healthcare (PHC) in cancer and can share their insights (via interactive polling) related to the value that PHC brings to various stakeholders, including but not limited to clinicians, patients, researchers and payers. Resources including printed reports and leaflets will be available and videos will be displayed to demonstrate Roche’s partnerships and leadership in improving health systems to address the cancer burden around the world.
Shared with National Cancer Centre Singapore
Established in 1964, Singapore Cancer Society (SCS) is a self-funded voluntary welfare organisation which is dedicated to minimising the impact of cancer in Singapore through the provision of cancer treatment subsidies, financial and welfare aid to needy cancer patients, home hospice care services for terminally-ill cancer patients, as well as rehabilitation support programmes for recovering cancer patients and cancer survivors.
In addition, the Society also provides cancer screening services at no cost and promotes cancer awareness and prevention through its public education and community outreach programmes. Annually, SCS helps more than 1,800 needy cancer patients and reaches out to more than 95,000 individuals in our community outreach programmes to encourage screening and early detection of cancers.
The Supportive Fund for Cancer Patients – “Bright Future” is a non-profit organization established on August 18, 2011 by Decision No.1583/QD-BNV of Ministry of Home Affairs. The fund has its main functions and tasks which are to support poor cancer patients nationwide; assist scientific research, train and promote cancer prevention as well as implement sponsors as authorize by the donors.
So far, the Fund has established its branches in Ho Chi Minh City, Can Tho, Hue, Da Nang, Phu Tho. 72 oncology hospitals/oncology centers or oncology departments across the country all have the collaborators of the Fund.
Sure, Inc. is a physician-led company focused on just one thing: providing a comfortable, accurate breast exam to the millions of women in the US and 95% of women globally who are not protected through traditional breast cancer screening. Sure, Inc. offers a unique use of a well-established technology – elastography – engaging women of all ages and providing a new kind of breast exam to close the gap that exists today with traditional screening efforts. We produce the SureTouch device – an FDA approved revolutionary medical device that provides a simple, painless breast exam without using any radiation. For women of all ages, SureTouch provides an augmented clinical breast examination that will detect abnormal masses including breast cancer. A medical practitioner who has had proper training and certification performs the examination. We provide examination services, engaging women through empowerment & action. No pain, no radiation, no side effects, no waiting for results. Offering both licensed and turnkey options, Sure, Inc operates globally and is headquartered in California, USA.
Activity: Join Dr. Joe Peterson, CEO of Sure, Inc and Mr. Martin Heller VP, Head of International Business Development as they demonstrate SureTouch. SureTouch is a unique medical device. Highly portable and effective in women of all ages, including those with dense breast tissue, as found in younger women and women of color. FDA-approved for over 10 years, SureTouch provides a new use of a well-established technology, elastography. Operated by nurses and technicians, it does not require specialized facilities, has a dedicated US CPT code, and uses no radiation with no side effects. Supported by a paired tablet and zero-footprint cloud-based information system which will be on display.
Taiwan Association of Medical Screening (TAMS) is a non-governmental organization assembling people from public health bureau, colleges, clinical institutes, and health industries in Taiwan. In Taiwan, we have launched the national organized service screening programs for cervical cancer with Pap smear/HPV testing since 1995, and breast cancer with mammography, colorectal cancer with fecal immunochemical test, and oral cancer with visual inspection by trained medical doctors since 2004. Although the inception is late in Taiwan compared with Western countries due to the consideration of low/intermediate incidence of cancer as the neighboring countries faced as well, we have demonstrated the effectiveness of cancer screening at the national level. In addition to cancer screening, we also promotes the community-based integrated screening which incorporates screening for chronic diseases as well. We anticipate that screening can be a platform to connect primary prevention and tertiary prevention in the era of precision medicine.
Our goals are therefore to
1. increase the professionalism of screening society,
2. evaluate screening program and ensure the quality of services,
3. promote the research of disease screening,
4. promote the international cooperation, and
5. promote cooperation with the government and academic community to facilitate the affairs of disease screening.
President King-Jen Chang and a group of physicians and volunteers founded the Taiwan Breast Cancer Foundation 21 years ago, with the vision of establishing a caring and supportive organization to provide services for breast cancer patients in Taiwan. For the past 21 years, the Foundation has hosted numerous activities including monthly forums for new patients, symposiums on cancer treatment and related topics and support groups with associated organizations. The foundation has also cooperated with many large-scale companies such as P&G and Skechers to provide free clinical services. Breast cancer remains the cancer with the highest incidence rate among Taiwanese women and the number of breast cancer patients has been steadily increasing in recent years. Its mission is to offer breast cancer patients information regarding diagnosis, treatments and provide counseling for emotional support. On the other hand, the foundation also encourage breast cancer related research in Taiwan. Through all its efforts, the foundation has been honored several national awards to recognize the contribution which its team has provided. The foundation will continue to promote the value of improving the quality of life for women and provide services for all women and breast cancer patients in Taiwan.
Dental Health Care Organization (DHCO) is organized by people from dental care, public health, clinics and hospitals in Taiwan to encourage the improvement of the oral health of the public. We serve our members and the public with valuable oral health information, advocacy and resources. Good oral health is key to improve overall health and life-quality.
Our goals are therefore to
1. Delivery oral health information from clinical to community,
2. Encourage people from not only dentistry but also physician, nurse, public health, and other relevant professionals to pay attention to dental health care.
3. promote the research of dental health care,
4. promote the international cooperation, and
5. cooperate with the government and academic community to promote the affairs of dental health care.
UE LifeSciences (UELS) is a US based medical technology innovation company working to bring affordable, socially acceptable and clinically effective access to early detection of breast cancer for 1 billion women worldwide.
iBreastExam (iBE), UELS’ flagship innovation, is a hand-held, radiation-free device operable by lay health workers for early detection of breast lumps at the point-of-care. Over 150,000 women have received the test in 12 countries. With promising results, iBE is clinically validated in USA, India, Brazil and Mexico in well over 10,000 women. With US FDA clearance, CE mark and other regulatory approvals, iBE is now commercially available and scaling in over 10 countries.
Using patented tactile sensor technology developed at Drexel University, for the first-time, women in the developing world have access to a safe, affordable, painless and standardized breast examination. The device is equally effective in younger women and women with dense breasts. iBE has won several coveted innovation awards and grants, including the Bayer and Pfizer Foundation grants, has been featured in the New York Times, BBC News and TED Talks.
Activity: Booth# E34 - Witness iBreastExam LIVE demo and Engage with our leadership team to explore partnership/collaboration opportunities!
The UE LifeSciences global team led by Professor Matthew Campisi (Co-Founder & CTO), Madhu Kumar (CEO, ASEAN), Dr. Rohan Khandelwal (Medical Director) and Akshat Shah (Head, Global Business Development) will be present and are keen to meet with key stakeholders - cancer societies, NGOs, governmental healthcare agencies and private healthcare providers, for whom early detection of breast cancer and pre-screening is a high priority.
“We unite the cancer community to reduce the global cancer burden, to promote greater equity, and to integrate cancer control into the world health and development agenda.”
The Talk Tent is a brand new networking activity which intends to strike up conversation with new colleagues, friends & relations under a WCC branded parasol that will appear in various places across the Global Village, including on the UICC stand. Be ready for an unconventional way to start talking!
UICC Networking Event at the UICC Stand at the Global Village – Thursday 4 October 9:30-10:30
Find out everything you need to know about the Union for International Cancer Control (UICC), how to engage in the work we do, the World Cancer Congress, World Cancer Leaders Summit and other convening platforms. Do you want to become a UICC member? Come to the UICC Stand to find out how. UICC has a number of capacity building opportunities and a global advocacy initiative, Treatment for All. Learn about this and more from UICC staff and leadership at the UICC Stand, at the centre of the Global Village.
Varian is a leader in developing and delivering cancer care solutions, and is focused on creating a world without fear of cancer. Headquartered in Palo Alto, California, Varian employs approximately 6,500 people around the world.
Activity: At Varian's booth, we have prepared an augmented reality (AR) app for the participants to visualize, understand and experience the features, workflow of our latest radiotherapy delivery system "Halcyon". Meet the experts.
“To prevent cancer and infectious diseases through excellence in the provision of public health supporting screening and vaccination.”
Australia is a world leader in achieving cervical cancer control in our population and it is time to extend that leadership to supporting cervical cancer prevention globally. VCS Foundation Limited (trading as VCS Foundation) has emerged from the long established and trusted Victorian Cytology Service, a laboratory service formed in 1964 to support cervical cancer screening when it was first introduced in Victoria, Australia.
VCS Foundation is a not for profit organisation drawing on over 50 years of expertise in cervical cancer prevention through laboratory and educational services, and 25 years of experience operating cancer screening and vaccination registries. These combined services have resulted in some of the lowest cervical cancer incidence and mortality rates globally.
VCS Foundation is a holistic entity that offers a comprehensive suite of services to support, monitor and manage population health programs, including screening and vaccination. This unique combination of services is proven to achieve better health outcomes and will ultimately save lives.
Wiley, a global company, helps people and organizations develop the skills and knowledge they need to succeed. Our online scientific, technical, medical, and scholarly journals, combined with our digital learning, assessment and certification solutions help universities, societies, businesses, governments, and individuals increase the academic and professional impact of their work.
Activity: Wiley is proud to partner with the UICC to publish The International Journal of Cancer (IJC) and a number of UICC books, including the bestselling TNM Classification of Malignant Tumours. Drop by booth E13 to browse some of the world’s leading Cancer research including an exclusive virtual issue from IJC and to check out the books. Also help us to highlight the UICC’s reach by plotting your location on our world map. We look forward to meeting you.
World Cancer Research Fund International leads and unifies a network of cancer prevention charities with a global reach. We champion the latest and most authoritative scientific research from around the world on cancer prevention and survival through diet, weight and physical activity, so that we can help people make informed lifestyle choices to reduce their cancer risk. We provide essential advice and guidance to help policymakers develop effective policies to reduce the cases of preventable cancer and other non-communicable diseases.
We are building a better, healthier future for people all over the world. Working with 194 Member States, across six regions, and from more than 150 offices, WHO staff are united in a shared commitment to achieve better health for everyone, everywhere. Together we strive to combat diseases – communicable diseases like influenza and HIV, and noncommunicable diseases like cancer and heart disease. We help mothers and children survive and thrive so they can look forward to a healthy old age. We ensure the safety of the air people breathe, the food they eat, the water they drink – and the medicines and vaccines they need
Activity: Meet the experts preliminarily planned for 3 October
More information soon
The Exhibitor Manual for the Global Village is now available. You can download it below.